MARTELLI, Massimo Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 7.424
EU - Europa 5.829
AS - Asia 4.301
SA - Sud America 701
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 18.327
Nazione #
US - Stati Uniti d'America 7.293
SG - Singapore 1.913
UA - Ucraina 1.133
IE - Irlanda 1.059
SE - Svezia 856
CN - Cina 698
HK - Hong Kong 694
IT - Italia 627
BR - Brasile 602
RU - Federazione Russa 565
DE - Germania 498
FI - Finlandia 416
VN - Vietnam 408
KR - Corea 292
GB - Regno Unito 236
FR - Francia 95
CA - Canada 69
BE - Belgio 60
TR - Turchia 54
IN - India 48
PL - Polonia 47
AR - Argentina 42
AT - Austria 42
MX - Messico 41
NL - Olanda 41
CZ - Repubblica Ceca 37
ZA - Sudafrica 32
UZ - Uzbekistan 31
JP - Giappone 29
CH - Svizzera 28
IQ - Iraq 26
BD - Bangladesh 22
EC - Ecuador 16
GR - Grecia 16
LT - Lituania 16
RO - Romania 16
CO - Colombia 15
ES - Italia 13
PK - Pakistan 10
ID - Indonesia 9
IL - Israele 9
LB - Libano 8
EU - Europa 7
VE - Venezuela 7
BG - Bulgaria 6
AZ - Azerbaigian 5
CL - Cile 5
MA - Marocco 5
PY - Paraguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
OM - Oman 4
PT - Portogallo 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
EG - Egitto 3
HR - Croazia 3
KG - Kirghizistan 3
MY - Malesia 3
PH - Filippine 3
PS - Palestinian Territory 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
GH - Ghana 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
Totale 18.316
Città #
Chandler 1.232
Singapore 1.226
Dublin 1.059
Hong Kong 691
San Mateo 670
Jacksonville 634
Boardman 396
Ashburn 365
Ann Arbor 304
Seoul 287
Santa Clara 277
Medford 226
Princeton 224
Dong Ket 215
Beijing 203
Altamura 191
Perugia 169
Wilmington 164
Andover 161
Moscow 159
Munich 154
Lawrence 140
Piscataway 117
Los Angeles 113
Helsinki 111
New York 105
Turku 81
Woodbridge 63
Saint Petersburg 62
Ho Chi Minh City 61
Brussels 57
Norwalk 53
São Paulo 45
Shanghai 44
Houston 43
Des Moines 40
Hanoi 40
The Dalles 39
Dearborn 34
London 34
Izmir 32
San Paolo di Civitate 32
Brooklyn 31
Frankfurt am Main 28
Tokyo 28
Auburn Hills 26
Dallas 26
Falkenstein 26
Warsaw 26
Stockholm 25
Council Bluffs 24
Brno 23
Johannesburg 23
Montreal 23
Phoenix 23
Atlanta 20
Chicago 20
Redwood City 20
Rio de Janeiro 20
Amsterdam 19
San Francisco 19
Denver 18
Bologna 17
Foligno 17
Belo Horizonte 15
Milan 15
Nuremberg 15
Orem 15
San Diego 15
Boston 14
Hefei 14
Guangzhou 13
Rome 13
Chennai 12
Espoo 12
Falls Church 12
Mexico City 12
Poplar 12
Redmond 12
Brasília 11
Charlotte 11
Florence 10
Vienna 10
Baghdad 9
Campinas 9
Changsha 9
Groningen 9
Quito 9
Toronto 9
Ankara 8
Bucharest 8
Guarulhos 8
Haiphong 8
Manchester 8
Ottawa 8
Tashkent 8
West Jordan 8
Bexley 7
Columbus 7
Da Nang 7
Totale 11.237
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 159
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 154
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 148
Innate immunity against hematological malignancies 133
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 133
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 128
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 127
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 126
14q+ chromosome marker in a T-cell-rich B-cell lymphoma. 125
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 125
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 122
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 120
Acute lymphoblastic leukaemia in Noonan syndrome 118
A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma 117
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 116
Graft engineering for allogeneic haploidentical stem cell transplantation 113
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 112
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 112
Mesenchymal cells: a vehicle for gene therapy 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 109
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 109
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 108
3q aberration and monosomy 7 in ANLL presenting with high platelet count and diabetes insipidus. 108
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 108
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 107
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 107
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia 106
Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies 106
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 106
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 106
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 104
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 104
5q- syndrome in a patient with chronic exposure to ionizing radiation. 103
5q- syndrome termi¬nating in acute myeloid leukemia: karyotype evolution and immunological characterization of blast cells. 101
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 100
A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement 99
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 99
"Designed" grafts for HLA-haploidentical stem cell transplantation. 99
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 99
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 98
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 97
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 97
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 96
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells 96
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 96
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 96
Transplants across human leukocyte antigen barriers 95
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 95
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 95
T regulatory cell separation for clinical application. 94
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 93
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 93
Decreased bone mineral density after autologous stem cell transplantation. 93
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 93
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases 93
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 92
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 92
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 92
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 92
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 91
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 91
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 91
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 91
Allogeneic transplantation across the HLA barriers. 91
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 91
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 90
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 90
Haploidentical stem cell transplantation for acute leukemia 89
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 89
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 89
The in vivo effect of thymic factor (thymostimulin) administration in Hodgkin's disease patients. Correlation of skin reactivity and leukocyte migration-inhibition factor in the sera of anergic subjects 88
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 88
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 88
AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer 88
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 87
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 87
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene 87
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 86
Natural killer cell alloreactivity for leukemia therapy. 86
. Mismatched hematopoietic stem cell transplants in elderly patients. 86
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 86
Cellular therapy: exploiting NK cell alloreactivity in transplantation 85
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia 85
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 85
Submicroscopic deletions in 5q- associated malignancies 85
Different genomic imbalances in low- and high-grade HCV-related lymphomas 84
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 84
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 84
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 84
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 84
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 83
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 83
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 83
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 83
Mismatched hematopoietic stem cell transplantation in secondary leukemia 82
Cytogenetic and FISH investigations on Tetrasomy 8 in ALL. 82
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 82
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 82
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 82
Totale 9.935
Categoria #
all - tutte 83.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.166 0 0 0 0 0 142 198 12 249 91 220 254
2021/20222.169 55 525 71 175 94 11 30 620 18 39 266 265
2022/20233.658 253 631 26 336 276 384 4 200 1.391 12 113 32
2023/20241.503 85 156 64 31 10 20 320 43 197 40 251 286
2024/20253.333 93 347 136 156 446 146 91 253 620 185 567 293
2025/20263.593 537 477 338 975 1.061 205 0 0 0 0 0 0
Totale 18.799